Analytical Data
-
基因名
LILRA5
- Application
-
别名
LILRA5；ILT11；LILRB7；LIR9；Leukocyte immunoglobulin-like receptor subfamily A member 5
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
A6NI73-1
-
表达区间
1-268aa
-
氨基酸序列
MAPWSHPSAQ LQPVGGDAVS PALMVLLCLG LSLGPRTHVQ AGNLSKATLW AEPGSVISRG NSVTIRCQGT LEAQEYRLVK EGSPEPWDTQ NPLEPKNKAR FSIPSMTEHH AGRYRCYYYS PAGWSEPSDP LELVVTGFYN KPTLSALPSP VVTSGENVTL QCGSRLRFDR FILTEEGDHK LSWTLDSQLT PSGQFQALFP VGPVTPSHRW MLRCYGSRRH ILQVWSEPSD LLEIPVSGAA DNLSPSQNKS DSGTASHLQD YAVENLIR
-
分子量
27 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LILRA5, a member of the Leukocyte Immunoglobulin-like Receptor (LILR) family, has garnered significant interest in immunological research due to its potential role in modulating immune responses. This receptor is primarily expressed on myeloid cells and is known to interact with various ligands, including major histocompatibility complex (MHC) molecules. The study of LILRA5 and its recombinant protein forms is pivotal for understanding its function in innate immunity, particularly in regulating inflammation and immune tolerance. Recent discoveries have implicated LILRA5 in several pathological conditions, including autoimmune diseases and infections, suggesting that it may serve as a therapeutic target or biomarker. Researchers are focusing on the expression and purification of LILRA5 recombinant proteins to elucidate their structural properties and binding affinities, which can provide insights into their biological roles. By studying these proteins, scientists aim to unravel the complexities of immune regulation and explore new avenues for treatment strategies in immune-related disorders. The ongoing research in this field underscores the significance of LILRA5 in both basic and translational immunology, highlighting its potential implications in enhancing our understanding of immune mechanisms and developing novel therapeutic interventions.
